In November 2022, Swiss Medic granted miVital AG the license to manufacture pharmaceutical products.
miVital's product is being distributed internationally with great success and is part of bigger studies in relation to the COVID-19 pandemic
Together with zenius Ltd., miVital AG establishes a cooperation with an experienced Japanese business partner.
miVital is fortunate to enjoy rapid growth and moves into specifically converted premises in the same building.
Today's established formulas are developed over years. In the same year, the first premises are occupied in the Startfeld Innovation Centre in St. Gallen.
miVital AG is founded in St. Gallen from a well-founded idea. First steps take place within EMPA in St. Gallen.